ライフサイエンスコーパス: hopelessness

1 ion of patients and between satisfaction and hopelessness.

2 < .001) but not for anxiety, depression, or hopelessness.

3 gy, suicide history, reasons for living, and hopelessness.

4 as anhedonia, guilt, suicidal thinking, and hopelessness.

5 may be motivated by depression or short-term hopelessness.

6 d significantly higher levels of depression, hopelessness, aggression, anxiety, impulsivity, and suic

7 y diverse debilitating symptoms that include hopelessness and anhedonia.

8 erized by symptoms such as reduced activity, hopelessness and depressed mood.

9 Hopelessness and impulsive aggression independently incr

10 by anhedonia, cognitive biases, ruminations, hopelessness and increased anxiety.

11 objective severity of depression, may modify hopelessness and may protect against suicidal behavior d

12 lated with depression severity, self-report 'hopelessness' and anxiety.

13 of life, whereas symptom distress, concerns, hopelessness, and negative appraisal of illness or careg

14 ikely to be religious, had higher scores for hopelessness, and rated their quality of life as lower.

15 he cognitive factors of attributional style, hopelessness, and self-esteem were assessed in subjects

16 he cognitive factors of attributional style, hopelessness, and self-esteem when suicidal ideation fad

17 among those with lower baseline depression, hopelessness, and self-reported anxiety.

18 Interventions addressing depression, hopelessness, and social support appear to be important

19 out a history of abuse, with lower levels of hopelessness, and with comorbid conditions.

20 dently predicted by nonsuicidal self-injury, hopelessness, anxiety disorder, and being younger and fe

21 h elevated scores on self-report measures of hopelessness, anxiety sensitivity, impulsivity, and sens

22 At week 12, lower depression, hopelessness, anxiety, suicidal ideation, family conflic

23 Prior attempted suicide and hopelessness are the most powerful clinical predictors o

24 Depression and hopelessness are the strongest predictors of desire for

25 v SGP) for quality of life, depression, and hopelessness but not for other outcome variables.

26 men with high scores on the helplessness and hopelessness category of the MAC scale compared with tho

27 nd caregiving, greater uncertainty, and more hopelessness compared with dyads in the newly diagnosed

28 associated with suicidal behaviour only (eg, hopelessness, depression, anxiety, quality of life).

29 to criteria modified for the medically ill (hopelessness, depression, or anhedonia were used as the

30 nificantly greater reductions in depression, hopelessness, desire for hastened death, and physical sy

31 ndary outcome measures assessing depression, hopelessness, desire for hastened death, anxiety, and ph

32 Evidence of hopelessness, helplessness, worthlessness, guilt, and su

33 episode alone on measures of depressed mood, hopelessness, impulsive aggression, and suicidal behavio

34 feelings of worthlessness, helplessness, and hopelessness, in the desipramine-mazindol but not in the

35 tress, depression, anxiety, uncertainty, and hopelessness interact with pain.

36 fect size across cases, these variables were hopelessness, lack of control, anxiety, feeling blocked,

37 predicted reduced levels of postconsultation hopelessness (linear change, -0.78; 95% CI, 1.44 to -0.1

38 t 1 depressive symptom (sadness, depression, hopelessness, loss of interest, or lack of pleasure) was

39 Levels of hopelessness of patients significantly decreased from pr

40 te and trainable PCC behaviors can lower the hopelessness of patients with breast cancer indirectly t

41 which, in turn, reduces the postconsultation hopelessness of patients.

42 psychological pain (e.g., social isolation, hopelessness), often in the context of mental disorders,

43 n increase in either impulsive aggression or hopelessness or a diagnosis of borderline personality di

44 on, decreased depressive severity, decreased hopelessness, or improved level of function.

45 evel of subjective and objective depression, hopelessness, or stressful life events were found.

46 ltivariate analyses, depression (P=.003) and hopelessness (P<.001) provided independent and unique co

47 of depressive symptom severity (P<.001) and hopelessness (P<.001).

48 n treatment, leukemia diagnosis, depression, hopelessness, pain, and physical appearance concern.

49 Hopelessness predicted lethal intent in all three groups

50 ing and desire for hastened death (r=-0.51), hopelessness (r=-0.68), and suicidal ideation (r=-0.41).

51 cluding suicidal and death-related thoughts, hopelessness, restlessness and agitation, insomnia and i

52 e Hamilton depression rating scale, the Beck hopelessness scale, and the schedule of attitudes toward

53 s, the Brief Symptom Inventory, and the Beck Hopelessness Scale; stage of HIV illness; and CD4 cell c

54 year event-free survival a high helplessness/hopelessness score has a moderate but detrimental effect

55 between certain psychosocial factors (e.g., hopelessness, social support) and cancer progression.

56 n secondary measures of depression, anxiety, hopelessness, stress, and quality of life.

57 Scores for hopelessness, subjective depression, and suicidal ideati

58 nts in the secondary outcomes of depression, hopelessness, suicidal ideation, and problem solving.

59 sures of psychological distress (depression, hopelessness, suicidal ideation, overall psychological d

60 ndary outcomes included anxiety, depression, hopelessness, symptom burden, and symptom-related distre

61 ase in depression severity and reported less hopelessness than the patients receiving usual care.

62 ility that depression can lead to a sense of hopelessness that erodes adherence and other health-prom

63 ng spirit or an attitude of helplessness and hopelessness toward the disease, has been suggested as a

64 style became significantly more positive and hopelessness was decreased from admission to discharge,

65 For example, hopelessness was significant in seven of the seven cases